3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Exercise
6
pembrolizumab
1
cemiplimab
1
beta-Glucans
1
avelumab
1
Tablets
1
Surveys and Questionnaires
1
Roflumilast
1
Nivolumab
1
Nadolol
1
Isoproterenol
1
Ipilimumab
1
Immune Checkpoint Inhibitors
1
Carvedilol
1
Bisoprolol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Motor Activity
×
Nadolol
×
Clear all
NCT06643221
2024-10-16
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
100 enrolled